Pharmaceutical - Markets & Marketing, Global

Filter

Current filters:

Markets & MarketingGlobal

Popular Filters

1 to 25 of 133 results

Health care and pharma execs optimistic about business conditions in 2015: Economist report

Health care and pharma execs optimistic about business conditions in 2015: Economist report

14-01-2015

More than half of pharma and healt care executives expect business conditions for their company to improve…

GlobalMarkets & MarketingPharmaceuticalPricingProductionResearch

Plasma fractionation market forecasts to 2019

06-01-2015

The global plasma fractionation market is witnessing continuous growth. The rise in aging population…

Baxter InternationalBio Product LaboratoryBiotestCSL LtdGlobalGrifolsHematologyKedrionLFB BiotechnologiesMarkets & MarketingOctapharmaPharmaceuticalSanquin

2015 will see blockbuster drug launches and more big M&A deals, report predicts

2015 will see blockbuster drug launches and more big M&A deals, report predicts

11-12-2014

Innovation will continue to drive the pharma and biotech sectors in 2015, according to EP Vantage’s…

GlobalHarvoniLCZ696Markets & MarketingPharmaceutical

Patent cliff means pharma will lose $65 billion by 2019, says report

Patent cliff means pharma will lose $65 billion by 2019, says report

11-12-2014

Pharmaceutical companies will suffer an estimated $65 billion drop in sales by 2019 due to the patent…

AbilifyAstraZenecaEli LillyGlobalMarkets & MarketingNeurologicalOtsukaPatentsPharmaceuticalSeroquelZyprexa

Global oncology market to hit $109 billion in 2020

Global oncology market to hit $109 billion in 2020

26-11-2014

Cancer, with a death toll exceeding that of AIDS (acquired immune deficiency syndrome), tuberculosis…

AvastinCelgene Corp.GlobalMarkets & MarketingMergers & AcquisitionsNovartisOncologyPharmaceuticalResearchRevlimidRoche

Acute myeloid leukemia treatment market will grow to $878.6 million by 2020

Acute myeloid leukemia treatment market will grow to $878.6 million by 2020

25-11-2014

The global acute myeloid leukemia therapeutics market is predicted to increase from $632.6 million in…

GlobalMarkets & MarketingmidostaurinOncologyPharmaceuticalquizartinib

Pharma companies can still improve access to medicines, report shows

Pharma companies can still improve access to medicines, report shows

17-11-2014

Top pharma companies are doing more to improve access to medicine in developing countries over the last…

GlaxoSmithKlineGlobalMarkets & MarketingNovo NordiskPharmaceuticalSanofi

Ulcerative colitis market to hit $4.2 billion by 2023

Ulcerative colitis market to hit $4.2 billion by 2023

13-11-2014

The ulcerative colitis market is set to grow from $2.7 billion in 2013 to $4.2 billion in 2023 in the…

Decision Resources GroupEntyvioGastro-intestinalsGlobalMarkets & MarketingPharmaceuticalRemicadeResearchXeljanz

ISPE unveils plan to prevent drug shortages

16-10-2014

Regulators from the European Medicines, the US Food and Drug Administration and the UK’s Medicines…

GlobalMarkets & MarketingPharmaceuticalProductionRegulation

Ultra-rapid-acting insulin formulations will revolutionize type 1 diabetes market by 2019

Ultra-rapid-acting insulin formulations will revolutionize type 1 diabetes market by 2019

08-10-2014

Ultra-rapid formulations of the currently marketed rapid-acting insulin analogs have the clear potential…

AdociaBioChaperoneDiabetesFIAspGlobalMarkets & MarketingNovo NordiskPharmaceuticalResearch

Roche could lose its dominant market share in breast cancer, says IMS report

Roche could lose its dominant market share in breast cancer, says IMS report

03-10-2014

Biosimilars and new generation agents will end the market dominance of established breast cancer drugs,…

AstraZenecaGlobalHerceptinMarkets & MarketingNovartisOncologyPharmaceuticalRochetamoxifen

New approach to global markets identifies six country archetypes

New approach to global markets identifies six country archetypes

02-10-2014

Similarities in pricing and reimbursement (P&R) decision criteria and payer requirements in key pharmaceutical…

GlobalMarkets & MarketingPharmaceuticalPharmaceutical industryRegulation

New report debunks some common perceptions of R&D productivity

New report debunks some common perceptions of R&D productivity

08-09-2014

The 2014 edition of the Thomson Reuters CMR Pharmaceutical R&D Factbook, published today, contains some…

GlobalMarkets & MarketingPharmaceuticalRegulationResearch

New treatments will partially compensate for unipolar depression drugs coming out of patent

New treatments will partially compensate for unipolar depression drugs coming out of patent

14-08-2014

New antidepressants and antipsychotics will offset a steep decline in sales following genericization…

Antidepressant therapiesDecision Resources GroupGlobalMarkets & MarketingNeurologicalPharmaceuticalPsychiatryUnipolar depression

Existing diabetes drug Victoza could be effective treatment for world’s obese

Existing diabetes drug Victoza could be effective treatment for world’s obese

06-08-2014

Pharmaceutical companies are racing to find a new form of obesity drug as patient numbers spiral and…

Anti-diabetic drugsDiabetesGastro-intestinalsGlobalMarkets & MarketingNovo NordiskPeptide hormonesPharmaceuticalVictoza

EXPERT VIEW: How can pharmaceutical companies adapt to the digital era?

EXPERT VIEW: How can pharmaceutical companies adapt to the digital era?

06-08-2014

‘Digital pharma’ is by no means a new concept for pharmaceutical marketers. But what is new is that…

FinancialGlobalMarkets & MarketingPharmaceutical

Albumin sales to play major part in growth of billion-dollar critical care market

Albumin sales to play major part in growth of billion-dollar critical care market

31-07-2014

The critical care market across eight major countries will grow to $2.5 billion by 2020, according to…

AlbuminBlood proteinsGlobalMarkets & MarketingPharmaceutical

New study identifies potential alternatives to Gilead’s Sovaldi

New study identifies potential alternatives to Gilead’s Sovaldi

29-07-2014

There are multiple hepatitis treatments in development that may serve as potential alternatives to Gilead…

AbbVieAntibiotics and Infectious diseasesBristol-Myers SquibbdaclatasvirGilead SciencesGlobalHepatitis C treatmentMarkets & MarketingmericitabinePharmaceuticalRocheSovaldi

Global insulin market set to reach $32.24 billion in 2019

Global insulin market set to reach $32.24 billion in 2019

28-07-2014

The global insulin market was valued at $19.99 billion in 2012 and is expected to expand at a compound…

AfrezzaChinaDiabetesEli LillyGlobalInsulinLY2605541MannKindMarkets & MarketingMerck & CoMK-1293NN1218Novo NordiskPharmaceutical

New treatments to boost hepatitis C market to $19.2 billion by 2016

New treatments to boost hepatitis C market to $19.2 billion by 2016

24-06-2014

The launch of interferon-free regimens is expected to boost the hepatitis C market from $2.9 billion…

Anti-viralsAntiviralsBusiness FinanceCytokinesDatamonitorGilead SciencesGlobalMajorMarkets & MarketingPharmaceuticalSovaldi

Pharma challenged by increasing global market access complexity

Pharma challenged by increasing global market access complexity

13-06-2014

New research indicates that global market access planning is growing in complexity as each country’s…

GlobalMarkets & MarketingPharmaceuticalRegulation

Worldwide pharma industry marketing investment flat in 2013

Worldwide pharma industry marketing investment flat in 2013

04-06-2014

Worldwide, industry investment in pharmaceuticals sales force and marketing channels remained flat in…

GlobalMarkets & MarketingPharmaceutical

1 to 25 of 133 results

COMPANY SPOTLIGHT

Menarini

Back to top